Open AccessStroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry
Author(s) -
JerjesSanchez Carlos,
Corbalan Ramon,
Barretto Antonio C. P.,
Luciardi Hector L.,
Allu Jagan,
Illingworth Laura,
Pieper Karen S.,
Kayani Gloria
Publication year - 2019
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.23176
Subject(s) - medicine , atrial fibrillation , antithrombotic , stroke (engine) , latin americans , major bleeding , oral anticoagulant , anticoagulant therapy , cardiology , warfarin , mechanical engineering , linguistics , philosophy , engineering
Atrial fibrillation (AF) is an important preventable cause of stroke. Anticoagulation (AC) therapy can reduce this risk. However, prescribing patterns and outcomes in patients with non-valvular AF (NVAF) from Latin American countries are poorly described.